(Stroke. 1996;27:709-711.)
© 1996 American Heart Association, Inc.
Articles |
Role of Platelet-Endothelial Cell Adhesion Molecule (PECAM) in Platelet Adhesion/Aggregation Over Injured but Not Denuded Endothelium In Vivo and Ex Vivo
From the Division of Neuropathology, Medical College of Virginia/Virginia Commonwealth University, Richmond (W.I.R., G.H.N., B.W.), and PharMingen, San Diego, Calif (P.W., J.W., C.C.-Y.S.).
Background and Purpose We previously demonstrated that a monoclonal antibody (MoAb) with anti-CD31, anti-platelet-endothelial cell adhesion molecule (PECAM)-like properties delayed platelet adhesion/aggregation at a site of minor endothelial injury. To our knowledge, this was the first in vivo demonstration of an effect of anti-CD31. There was no exposure of collagen or basal lamina at the injured site, and the modulation of adhesion/aggregation at such sites has not received much study. The present investigation attempted to replicate the first with the use of a different MoAb, definitely characterized as anti-PECAM. In addition, an ex vivo investigation was performed to see whether the in vivo action of anti-PECAM could have been caused by an effect of the MoAb on the platelets rather than on the endothelium.
Methods A helium-neon laser, in the presence of intravascular Evans blue, was used to injure the endothelium of arterioles on the surface of the mouse brain. Intravital microscopy was used to determine the number of seconds required for the light to initiate the first recognizable platelet aggregate forming at the injured site. Mice injected with vehicle were compared with mice injected with 2 mg/kg anti-PECAM through the tail vein. The injection was 10 minutes before challenge with the laser. Additional studies were performed of aggregation produced in vitro by arachidonate and by ADP added to platelet-rich plasma (PRP) prepared from blood taken from MoAb-treated and vehicle-treated mice.
Results Aggregation latency was significantly prolonged (P<.02) by anti-PECAM (121±59 versus 65±26 seconds in controls; n=10 each). Aggregation ex vivo was not affected.
Conclusions PECAM is an important modulator of platelet adhesion/aggregation at sites of minor endothelial damage in brain arterioles. The data are consistent with the hypothesis that PECAM sites on the endothelium are involved and may be exposed by the injury to promote adhesion/aggregation. Since the endothelial cell layer is intact at these sites, mechanisms such as this offer important alternatives to the more commonly studied pathways of platelet activation, which require exposure of collagen and are not applicable in this model.
Key Words: cerebral arteries • endothelium • platelet aggregation • mice
This article has been cited by other articles:
 |
|
 |
|
  S. Falati, S. Patil, P. L. Gross, M. Stapleton, G. Merrill-Skoloff, N. E. Barrett, K. L. Pixton, H. Weiler, B. Cooley, D. K. Newman, et al. Platelet PECAM-1 inhibits thrombus formation in vivo Blood, January 15, 2006; 107(2): 535 - 541. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. P. Tull, S. I. Anderson, S. C. Hughan, S. P. Watson, G. B. Nash, and G. E. Rainger Cellular Pathology of Atherosclerosis: Smooth Muscle Cells Promote Adhesion of Platelets to Cocultured Endothelial Cells Circ. Res., January 6, 2006; 98(1): 98 - 104. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Kojima, H. Kanada, S. Shimizu, E. Kasama, K. Shibuya, H. Nakauchi, T. Nagasawa, and A. Shibuya CD226 Mediates Platelet and Megakaryocytic Cell Adhesion to Vascular Endothelial Cells J. Biol. Chem., September 19, 2003; 278(38): 36748 - 36753. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Lagadec, O. Dejoux, M. Ticchioni, F. Cottrez, M. Johansen, E. J. Brown, and A. Bernard Involvement of a CD47-dependent pathway in platelet adhesion on inflamed vascular endothelium under flow Blood, June 15, 2003; 101(12): 4836 - 4843. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. J. Newman and D. K. Newman Signal Transduction Pathways Mediated by PECAM-1: New Roles for an Old Molecule in Platelet and Vascular Cell Biology Arterioscler. Thromb. Vasc. Biol., June 1, 2003; 23(6): 953 - 964. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Morigi, M. Galbusera, E. Binda, B. Imberti, S. Gastoldi, A. Remuzzi, C. Zoja, and G. Remuzzi Verotoxin-1-induced up-regulation of adhesive molecules renders microvascular endothelial cells thrombogenic at high shear stress Blood, September 15, 2001; 98(6): 1828 - 1835. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J J Nissen, D Mantle, B Gregson, and A D Mendelow Serum concentration of adhesion molecules in patients with delayed ischaemic neurological deficit after aneurysmal subarachnoid haemorrhage: the immunoglobulin and selectin superfamilies J. Neurol. Neurosurg. Psychiatry, September 1, 2001; 71(3): 329 - 333. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. L. Jones, S. C. Hughan, S. M. Dopheide, R. W. Farndale, S. P. Jackson, and D. E. Jackson Platelet endothelial cell adhesion molecule-1 is a negative regulator of platelet-collagen interactions Blood, September 1, 2001; 98(5): 1456 - 1463. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Andre, C. V. Denis, J. Ware, S. Saffaripour, R. O. Hynes, Z. M. Ruggeri, and D. D. Wagner Platelets adhere to and translocate on von Willebrand factor presented by endothelium in stimulated veins Blood, November 15, 2000; 96(10): 3322 - 3328. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Mahooti, D. Graesser, S. Patil, P. Newman, G. Duncan, T. Mak, and J. A. Madri PECAM-1 (CD31) Expression Modulates Bleeding Time in Vivo Am. J. Pathol., July 1, 2000; 157(1): 75 - 81. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Bombeli, B. R. Schwartz, and J. M. Harlan Endothelial Cells Undergoing Apoptosis Become Proadhesive for Nonactivated Platelets Blood, June 1, 1999; 93(11): 3831 - 3838. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Quarmby, P. Kumar, J. Wang, J. A. Macro, J. J. Hutchinson, R. D. Hunter, and S. Kumar Irradiation Induces Upregulation of CD31 in Human Endothelial Cells Arterioscler. Thromb. Vasc. Biol., March 1, 1999; 19(3): 588 - 597. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. S. Duncan, D. P. Andrew, H. Takimoto, S. A. Kaufman, H. Yoshida, J. Spellberg, J. Luis de la Pompa, A. Elia, A. Wakeham, B. Karan-Tamir, et al. Genetic Evidence for Functional Redundancy of Platelet/Endothelial Cell Adhesion Molecule-1 (PECAM-1): CD31-Deficient Mice Reveal PECAM-1-Dependent and PECAM-1-Independent Functions J. Immunol., March 1, 1999; 162(5): 3022 - 3030. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
V. L. Serebruany and P. A. Gurbel Effect of Thrombolytic Therapy on Platelet Expression and Plasma Concentration of PECAM-1 (CD31) in Patients With Acute Myocardial Infarction Arterioscler. Thromb. Vasc. Biol., January 1, 1999; 19(1): 153 - 158. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Bombeli, B. R. Schwartz, and J. M. Harlan Adhesion of Activated Platelets to Endothelial Cells: Evidence for a GPIIbIIIa-dependent Bridging Mechanism and Novel Roles for Endothelial Intercellular Adhesion Molecule 1 (ICAM-1), alpha vbeta 3 Integrin, and GPIbalpha J. Exp. Med., February 2, 1998; 187(3): 329 - 339. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
X.-W. Wu and E. C.-Y. Lian Binding Properties and Inhibition of Platelet Aggregation by a Monoclonal Antibody to CD31 (PECAM-1) Arterioscler. Thromb. Vasc. Biol., November 1, 1997; 17(11): 3154 - 3158. [Abstract] [Full Text]
|
|
|
|
 |
|
 S. A. Mousa, D.-X. Mu, and B. R. Lucchesi Prevention of Carotid Artery Thrombosis by Oral Platelet GPIIb/IIIa Antagonist in Dogs Stroke, April 1, 1997; 28(4): 830 - 836. [Abstract] [Full Text]
|
|